Abstract

Medicinal Chemistry: A Series of Monographs, Volume 13–II presents the context of inflammation and the therapeutic interventions in debilitating chronic inflammatory diseases. This book discusses the progress of therapeutics in the field of medicine with less cost but with the same degree of benefit.
Comprised of 10 chapters, this volume begins with a discussion on the pathophysiological context of chronic inflammatory diseases. This book then explores the local hormones that act as alarm signals following a local injury, which includes serotonin, histamine, kinins, heparin, prostaglandin, adenylates, lysolecithins, and catecholamines. Other chapters feature contributors who have active research on the clinical evaluation and treatment of severely debilitating chronic inflammatory diseases, including gout, arthritis, rheumatoid arthritis, osteoarthritis, psoriasis, and systemic lupus erythematosus. The final chapter explores the metabolism of anti-inflammatory drugs that are organized around chemical classes of compounds.
This book is a valuable source of information for physicians, chemists, and experimental biologists.